The CBOE Volatility index, Wall Street's fear gauge, closed up 3.4 points at 22.64, marking its biggest one-day points gain ...

Wall Street jumped by the most in three weeks as a rally in technology stocks pushed the S&P 500 to within one-fifth of a percentage point from a record high close.

Once thought of as a disease of age, new data about heart attacks is worrisome since it shows that it’s happening more often ...

Current health news highlights WeightWatchers offering a compound version of Novo Nordisk's obesity drug, Danco seeking FDA ...

--Pfizer's Chief Executive Albert Bourla plans to meet Starboard Value next week with at least one other director after the activist investor acquired a $1 billion stake in the healthcare company, the ...

Responding to growing pressure, ViiV Healthcare announced steps to widen access to its HIV prevention medicine in low- and ...

GSK announced on Tuesday that a single dose of its Arexvy vaccine against respiratory syncytial virus (RSV) was 43.3% ...

In another blow to its $525 million buyout of ReViral, Pfizer has ended development of sisunatovir, an oral inhibitor ...

Former executives of the pharmaceutical giant are backing a push by activist investor Starboard Value to turn aro ...

Pfizer CEO Albert Bourla plans to meet activist investor Starboard Value, the Financial Times reported on Tuesday, citing ...

Over the summer, the Biomedical Emerging Technology Applications (BETA) Summer Fellows Industry Program provided six ...

Pfizer (PFE) discontinues development of experimental RSV therapy sisunatovir from pipeline in a blow for its $525M ...